• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分析免疫接种具红细胞疟疾疟原虫 PfEMP1 的不同 NTS-DBL1α 结构域诱导的抗体反应。

Analysis of antibody induction upon immunization with distinct NTS-DBL1α-domains of PfEMP1 from rosetting Plasmodium falciparum parasites.

机构信息

Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, SE-17177, Sweden.

出版信息

Malar J. 2013 Jan 24;12:32. doi: 10.1186/1475-2875-12-32.

DOI:10.1186/1475-2875-12-32
PMID:23347690
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3599323/
Abstract

BACKGROUND

Rosette-formation of Plasmodium falciparum parasitized erythrocytes is of importance in the development of severe malaria. The parasite-derived molecule PfEMP1 (Plasmodium falciparum erythrocyte membrane protein 1), central to rosetting, is suggested to be included in a multimeric vaccine targeting severe disease.

METHODS

Three recombinant NTS-DBL1α-domains of PfEMP1 were generated in Escherichia coli, purified and used for immunization of rats and goats. Antibody titres were determined in ELISA assays and responses were compared in-between different individual animals and species. Reactivity with the parasites was tested in live pRBC using FACS. B-cell epitopes prediction was carried out in silico and compared to the results obtained by peptide microarray. Screening for serological cross-reactivity with heterologous NTS-DBL1α variants was carried out by ELISA, peptide array and FACS on pRBC of different laboratory strains and patient isolates.

RESULTS

All three NTS-DBL1α-domains induced high titres of antibodies that were biologically active with no apparent difference between constructs covering slightly different parts of the DBL1α-sequence. The different animal species showed comparable titres of antibodies, while variations within individuals of the species could be observed.Mapping of the recognized epitopes revealed that most parts of the molecule were able to induce an antibody response with a tendency for the N and C terminal parts of the molecule for slightly higher recognition. Important differences to the epitopes predicted were found as some of the most conserved parts of the DBL1α-domain contained the main epitopes for antibody reactivity. ELISA assays and peptide microarray demonstrated substantial cross-reactivity to heterologous variants, while binding to native PfEMP1 was observed only in few combinations on the pRBC surface, underlining that mainly internal, conserved and not surface exposed parts of the DBL1α-domain are responsible for this observation.

CONCLUSION

Biologically active antibodies can be induced consistently, with high titres, in different animal species and the antibodies elicited by different constructs react with similar epitopes. Induced antibodies recognize epitopes localized in all subdomains of the DBL1α-sequence. Cross-reactivity between NTS-DBL1α-variants is common in ELISA, but rare with live pRBC emphasizing that also internal, conserved areas of PfEMP1 carry important highly immunogenic epitopes of the molecule.

摘要

背景

恶性疟原虫寄生红细胞的玫瑰花形成在严重疟疾的发展中很重要。寄生虫衍生的分子 PfEMP1(恶性疟原虫红细胞膜蛋白 1)是玫瑰花形成的核心,被认为包含在针对严重疾病的多价疫苗中。

方法

在大肠杆菌中生成了三个重组 PfEMP1 的 NTS-DBL1α 结构域,进行了纯化并用于大鼠和山羊的免疫接种。通过 ELISA 测定抗体滴度,并在不同个体动物和物种之间进行比较。使用 FACS 在活 pRBC 上测试与寄生虫的反应。通过计算机进行 B 细胞表位预测,并与肽微阵列的结果进行比较。通过 ELISA、肽阵列和 FACS 在不同实验室株和患者分离株的 pRBC 上筛选与异源 NTS-DBL1α 变体的血清学交叉反应性。

结果

所有三个 NTS-DBL1α 结构域都诱导了高滴度的抗体,这些抗体具有生物活性,构建物覆盖的 DBL1α 序列略有不同,但没有明显差异。不同的动物物种显示出可比的抗体滴度,而在物种内的个体中可以观察到变化。识别表位的映射表明,分子的大部分区域都能够诱导抗体反应,分子的 N 和 C 末端区域略有更高的识别。与预测的表位存在重要差异,因为 DBL1α 结构域的一些最保守部分包含抗体反应的主要表位。ELISA 测定和肽微阵列显示与异源变体具有实质性的交叉反应性,而在 pRBC 表面仅观察到少数组合与天然 PfEMP1 结合,这表明主要是内部、保守的而不是表面暴露的 DBL1α 结构域负责这种观察结果。

结论

可以在不同的动物物种中一致地诱导具有高滴度的生物活性抗体,并且不同构建物诱导的抗体与类似的表位反应。诱导的抗体识别 DBL1α 序列的所有亚结构域中的表位。NTS-DBL1α 变体之间的交叉反应性在 ELISA 中很常见,但与活 pRBC 很少见,这强调 PfEMP1 的内部、保守区域也携带该分子的重要高度免疫原性表位。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ced/3599323/823bc00511fd/1475-2875-12-32-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ced/3599323/fc2e41111769/1475-2875-12-32-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ced/3599323/becf07f6e38a/1475-2875-12-32-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ced/3599323/ad85d4f77895/1475-2875-12-32-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ced/3599323/e2eb5bd290cc/1475-2875-12-32-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ced/3599323/fd1a825ea3b6/1475-2875-12-32-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ced/3599323/cb7c2362d25c/1475-2875-12-32-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ced/3599323/823bc00511fd/1475-2875-12-32-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ced/3599323/fc2e41111769/1475-2875-12-32-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ced/3599323/becf07f6e38a/1475-2875-12-32-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ced/3599323/ad85d4f77895/1475-2875-12-32-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ced/3599323/e2eb5bd290cc/1475-2875-12-32-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ced/3599323/fd1a825ea3b6/1475-2875-12-32-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ced/3599323/cb7c2362d25c/1475-2875-12-32-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ced/3599323/823bc00511fd/1475-2875-12-32-7.jpg

相似文献

1
Analysis of antibody induction upon immunization with distinct NTS-DBL1α-domains of PfEMP1 from rosetting Plasmodium falciparum parasites.分析免疫接种具红细胞疟疾疟原虫 PfEMP1 的不同 NTS-DBL1α 结构域诱导的抗体反应。
Malar J. 2013 Jan 24;12:32. doi: 10.1186/1475-2875-12-32.
2
Phagocytosis-inducing antibodies to Plasmodium falciparum upon immunization with a recombinant PfEMP1 NTS-DBL1α domain.用重组恶性疟原虫红细胞膜蛋白1(PfEMP1)NTS-DBL1α结构域免疫后产生的诱导吞噬作用的抗恶性疟原虫抗体。
Malar J. 2016 Aug 17;15(1):416. doi: 10.1186/s12936-016-1459-3.
3
B-cell epitopes in NTS-DBL1α of PfEMP1 recognized by human antibodies in Rosetting Plasmodium falciparum.恶性疟原虫红细胞凝集反应中人类抗体识别的PfEMP1的NTS-DBL1α中的B细胞表位。
PLoS One. 2014 Dec 1;9(12):e113248. doi: 10.1371/journal.pone.0113248. eCollection 2014.
4
Plasmodium falciparum rosetting epitopes converge in the SD3-loop of PfEMP1-DBL1α.恶性疟原虫环化表位集中在 PfEMP1-DBL1α 的 SD3 环上。
PLoS One. 2012;7(12):e50758. doi: 10.1371/journal.pone.0050758. Epub 2012 Dec 5.
5
Immunogenicity of the Plasmodium falciparum PfEMP1-VarO Adhesin: Induction of Surface-Reactive and Rosette-Disrupting Antibodies to VarO Infected Erythrocytes.恶性疟原虫PfEMP1-VarO黏附素的免疫原性:诱导针对感染VarO的红细胞的表面反应性和玫瑰花结破坏抗体。
PLoS One. 2015 Jul 29;10(7):e0134292. doi: 10.1371/journal.pone.0134292. eCollection 2015.
6
Immunisation with recombinant PfEMP1 domains elicits functional rosette-inhibiting and phagocytosis-inducing antibodies to Plasmodium falciparum.用重组 PfEMP1 结构域免疫可诱导针对恶性疟原虫的功能性红细胞花环抑制和吞噬诱导抗体。
PLoS One. 2011 Jan 31;6(1):e16414. doi: 10.1371/journal.pone.0016414.
7
Allelic diversity of the Plasmodium falciparum erythrocyte membrane protein 1 entails variant-specific red cell surface epitopes.恶性疟原虫红细胞膜蛋白 1 的等位基因多样性导致了变异体特异性的红细胞表面表位。
PLoS One. 2011 Jan 27;6(1):e16544. doi: 10.1371/journal.pone.0016544.
8
Immunization with PfEMP1-DBL1alpha generates antibodies that disrupt rosettes and protect against the sequestration of Plasmodium falciparum-infected erythrocytes.用PfEMP1-DBL1α进行免疫接种可产生抗体,这些抗体可破坏玫瑰花结形成,并防止恶性疟原虫感染的红细胞发生滞留。
Vaccine. 2004 Jul 29;22(21-22):2701-12. doi: 10.1016/j.vaccine.2004.02.015.
9
The antibody response to Plasmodium falciparum Merozoite Surface Protein 4: comparative assessment of specificity and growth inhibitory antibody activity to infection-acquired and immunization-induced epitopes.对恶性疟原虫裂殖子表面蛋白 4 的抗体反应:对感染获得和免疫诱导表位的特异性和生长抑制抗体活性的比较评估。
Malar J. 2011 Sep 16;10:266. doi: 10.1186/1475-2875-10-266.
10
A sequence in subdomain 2 of DBL1α of Plasmodium falciparum erythrocyte membrane protein 1 induces strain transcending antibodies.恶性疟原虫红细胞膜蛋白 1 的 DBL1α 亚结构域 2 中的一个序列诱导了跨越株系的抗体。
PLoS One. 2013;8(1):e52679. doi: 10.1371/journal.pone.0052679. Epub 2013 Jan 15.

引用本文的文献

1
Pathogenicity and virulence of malaria: Sticky problems and tricky solutions.疟疾的致病性和毒力:棘手的问题和巧妙的解决方案。
Virulence. 2023 Dec;14(1):2150456. doi: 10.1080/21505594.2022.2150456.
2
Expression of Single-Domain Soluble and Disulfide-Folded PfEMP1 Antigens in the Escherichia coli SHuffle Expression System.在大肠杆菌 SHuffle 表达系统中表达单结构域可溶性和二硫键折叠的 PfEMP1 抗原。
Methods Mol Biol. 2022;2470:273-282. doi: 10.1007/978-1-0716-2189-9_20.
3
Red blood cell blood group A antigen level affects the ability of heparin and PfEMP1 antibodies to disrupt Plasmodium falciparum rosettes.

本文引用的文献

1
Plasmodium falciparum rosetting epitopes converge in the SD3-loop of PfEMP1-DBL1α.恶性疟原虫环化表位集中在 PfEMP1-DBL1α 的 SD3 环上。
PLoS One. 2012;7(12):e50758. doi: 10.1371/journal.pone.0050758. Epub 2012 Dec 5.
2
Structural basis for the ABO blood-group dependence of Plasmodium falciparum rosetting.裂殖疟原虫环型形成依赖 ABO 血型的结构基础。
PLoS Pathog. 2012;8(7):e1002781. doi: 10.1371/journal.ppat.1002781. Epub 2012 Jul 12.
3
Induction of strain-transcending antibodies against Group A PfEMP1 surface antigens from virulent malaria parasites.
红细胞血型 A 抗原水平影响肝素和 PfEMP1 抗体破坏恶性疟原虫环状体的能力。
Malar J. 2021 Nov 18;20(1):441. doi: 10.1186/s12936-021-03975-w.
4
Rapid Response to Pandemic Threats: Immunogenic Epitope Detection of Pandemic Pathogens for Diagnostics and Vaccine Development Using Peptide Microarrays.应对大流行威胁的快速反应:使用肽微阵列进行诊断和疫苗开发的大流行病原体的免疫原性表位检测。
J Proteome Res. 2020 Nov 6;19(11):4339-4354. doi: 10.1021/acs.jproteome.0c00484. Epub 2020 Sep 21.
5
Antibodies in children with malaria to PfEMP1, RIFIN and SURFIN expressed at the Plasmodium falciparum parasitized red blood cell surface.疟疾患儿针对恶性疟原虫寄生红细胞表面表达的 PfEMP1、RIFIN 和 SURFIN 的抗体。
Sci Rep. 2018 Feb 19;8(1):3262. doi: 10.1038/s41598-018-21026-4.
6
Phagocytosis-inducing antibodies to Plasmodium falciparum upon immunization with a recombinant PfEMP1 NTS-DBL1α domain.用重组恶性疟原虫红细胞膜蛋白1(PfEMP1)NTS-DBL1α结构域免疫后产生的诱导吞噬作用的抗恶性疟原虫抗体。
Malar J. 2016 Aug 17;15(1):416. doi: 10.1186/s12936-016-1459-3.
7
Progress and prospects for blood-stage malaria vaccines.血液期疟疾疫苗的进展与前景
Expert Rev Vaccines. 2016 Jun;15(6):765-81. doi: 10.1586/14760584.2016.1141680. Epub 2016 Feb 3.
8
Evasion of Immunity to Plasmodium falciparum: Rosettes of Blood Group A Impair Recognition of PfEMP1.恶性疟原虫免疫逃逸:A 血型红细胞玫瑰花结损害对 PfEMP1 的识别。
PLoS One. 2015 Dec 29;10(12):e0145120. doi: 10.1371/journal.pone.0145120. eCollection 2015.
9
Immunogenicity of the Plasmodium falciparum PfEMP1-VarO Adhesin: Induction of Surface-Reactive and Rosette-Disrupting Antibodies to VarO Infected Erythrocytes.恶性疟原虫PfEMP1-VarO黏附素的免疫原性:诱导针对感染VarO的红细胞的表面反应性和玫瑰花结破坏抗体。
PLoS One. 2015 Jul 29;10(7):e0134292. doi: 10.1371/journal.pone.0134292. eCollection 2015.
10
RIFINs are adhesins implicated in severe Plasmodium falciparum malaria.RIFINs 是与严重的恶性疟原虫疟疾相关的黏附素。
Nat Med. 2015 Apr;21(4):314-7. doi: 10.1038/nm.3812. Epub 2015 Mar 9.
诱导针对强毒疟原虫表面抗原 A 群 PfEMP1 的跨株抗体。
PLoS Pathog. 2012;8(4):e1002665. doi: 10.1371/journal.ppat.1002665. Epub 2012 Apr 19.
4
Combined effects of Gm or Km immunoglobulin allotypes and age on antibody responses to Plasmodium falciparum VarO rosetting variant in Benin.在贝宁,Gm 或 Km 免疫球蛋白同种型与年龄对疟原虫 falciparum VarO 成帽变异体抗体反应的联合效应。
Microbes Infect. 2011 Aug;13(8-9):771-5. doi: 10.1016/j.micinf.2011.04.001. Epub 2011 Apr 13.
5
Differential induction of functional IgG using the Plasmodium falciparum placental malaria vaccine candidate VAR2CSA.利用疟原虫 falciparum 胎盘疟疾疫苗候选物 VAR2CSA 诱导功能性 IgG 的差异。
PLoS One. 2011 Mar 25;6(3):e17942. doi: 10.1371/journal.pone.0017942.
6
Immunisation with recombinant PfEMP1 domains elicits functional rosette-inhibiting and phagocytosis-inducing antibodies to Plasmodium falciparum.用重组 PfEMP1 结构域免疫可诱导针对恶性疟原虫的功能性红细胞花环抑制和吞噬诱导抗体。
PLoS One. 2011 Jan 31;6(1):e16414. doi: 10.1371/journal.pone.0016414.
7
Allelic diversity of the Plasmodium falciparum erythrocyte membrane protein 1 entails variant-specific red cell surface epitopes.恶性疟原虫红细胞膜蛋白 1 的等位基因多样性导致了变异体特异性的红细胞表面表位。
PLoS One. 2011 Jan 27;6(1):e16544. doi: 10.1371/journal.pone.0016544.
8
var gene transcription and PfEMP1 expression in the rosetting and cytoadhesive Plasmodium falciparum clone FCR3S1.2.导致裂殖体和黏附的恶性疟原虫克隆 FCR3S1.2 中转录和 PfEMP1 表达的 var 基因。
Malar J. 2011 Jan 25;10:17. doi: 10.1186/1475-2875-10-17.
9
The humoral response to Plasmodium falciparum VarO rosetting variant and its association with protection against malaria in Beninese children.对恶性疟原虫 VarO 成缗现象变异体的体液免疫应答及其与贝宁儿童疟疾保护作用的关系。
Malar J. 2010 Oct 5;9:267. doi: 10.1186/1475-2875-9-267.
10
Biochemical and biophysical characterisation of DBL1alpha1-varO, the rosetting domain of PfEMP1 from the VarO line of Plasmodium falciparum.恶性疟原虫VarO株PfEMP1的红细胞凝集结构域DBL1alpha1-varO的生化与生物物理特性分析
Mol Biochem Parasitol. 2010 Apr;170(2):84-92. doi: 10.1016/j.molbiopara.2009.12.008. Epub 2010 Jan 4.